Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Fertil Steril ; 90(1): 84-91, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17889864

ABSTRACT

OBJECTIVE: To determine whether laser-assisted hatching can improve clinical outcome of assisted reproductive techniques in patients with advanced female age, with recurrent implantation failure, or who are using frozen-thawed embryos. DESIGN: A prospective randomized study. SETTING: The infertility and IVF unit at a research facility in Iran. PATIENT(S): Four hundred ten patients with advanced female age (> or =37 y), 796 patients with recurrent implantation failure (for > or =2 cycles), and 180 patients with frozen-thawed embryos. INTERVENTION(S): Patients were divided equally into test and control groups. On the day of embryo transfer, the zona pellucida of the selected embryos in the test group were opened about 40 mum by using an infrared optical laser system, whereas in the control group they were all intact. MAIN OUTCOME MEASURE(S): Clinical pregnancy rates and implantation rates. RESULT(S): In the patients with advanced female age or recurrent implantation failure, the clinical pregnancy and implantation rates were similar for the test and control groups. However, in the patients with frozen-thawed embryos, the rates were statistically significantly higher in the test group as compared with those of the control group (31.2% and 12.8% vs. 11.1% and 4.2%, respectively). CONCLUSION(S): The laser-assisted hatching improved the pregnancy and implantation rates in patients with frozen-thawed embryos but had no effect in patients with advanced female age or recurrent implantation failure.


Subject(s)
Cryopreservation , Embryo Implantation , Embryo Transfer , Infertility/therapy , Infrared Rays , Lasers , Reproductive Techniques, Assisted , Zona Pellucida/radiation effects , Adult , Age Factors , Female , Humans , Pregnancy , Pregnancy Rate , Prospective Studies , Treatment Failure
3.
J Reprod Med ; 52(6): 503-12, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17694968

ABSTRACT

OBJECTIVE: To investigate the structure of epithelial cells from the human oviduct and uterus on extracellular matrix (ECM) gel in the first passage. STUDY DESIGN: Human oviducts and endometrial tissues were obtained from patients undergoing total hysterectomy; the epithelial cells, having been isolated by enzyme digestion, were cultured on polystyrene plastic surfaces. The epithelial nature of the cells was confirmed by immunocytochemistry, and their morphology was examined by microscopy. Cells of an epithelial nature were then trypsinized and cultured on an ECM gel-coated filter insert for 5 days. The cells, in parallel with the tissues, were subsequently prepared for transmission electron microscopy. RESULTS: Plastic-cultured cells had no sign of differentiation and appeared as elongated spindle cells in sections. These cells looked columnar and highly polarized after being cultured on ECM gel surfaces. They were similar to epithelial cells from the corresponding tissue fragment. Cultured on ECM gel, the ciliated epithelial cells of human oviducts appeared ultrastructurally similar to glandular cells from the human uterus. Cilia did not form under culture conditions. CONCLUSIONS: It seems that human uterine and oviduct epithelial cells can acquire polarized morphology and differentiated states on ECM gel after having lost it on plastic surfaces and that ECM gel by itself is not enough to induce cilia formation in culture.


Subject(s)
Cell Culture Techniques , Epithelial Cells/ultrastructure , Fallopian Tubes/cytology , Uterus/cytology , Cell Differentiation , Cells, Cultured , Cilia/ultrastructure , Extracellular Matrix , Female , Gels , Humans , Immunohistochemistry , Luteal Phase/physiology , Microscopy, Electron, Transmission , Plastics
4.
Curr Neurovasc Res ; 4(3): 153-60, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17691968

ABSTRACT

The CD133(+) bone marrow cell (BMC) population includes primitive multipotent stem cells which induce neoangiogenesis. Studies suggested transplantation of these cells to infarcted myocardium can have a favorable impact on tissue perfusion and contractile performance. We assessed the feasibility, safety and functional outcomes of autologus CD133(+) BMC transplantation during coronary artery bypass grafting (CABG) in patients with recent myocardial infarction. In a prospective, nonrandomized, open-label study, 27 patients with recent myocardial infarction underwent CABG and intramyocardial injection of autologous bone marrow-derived CD133(+) cells (18 patients, BMC group) or CABG alone (9 patients, control group). At 6 months after CABG, the Wall Motion Score Index (WMSI) was significantly reduced for akinetic/dyskinetic segments treated with CD133(+) cells compared with the control group (P<0.006). Likewise, comparison between baseline and follow up results of dobutamine stress echocardiography and myocardial perfusion scintigraphy showed improvement of myocardial viability and local perfusion of the infarcted zone of the BMC group compared with the control group. No complications related to CD133(+) cell transplantation were noted, either procedurally or during postoperative at a mean of 14 months follow up. In patients with recent myocardial infarction, transplantation of CD133(+) cells to the peri-infarct zone during CABG surgery is feasible and safe, with no evidence of early or late adverse events. Moreover, these cells might restore tissue viability and improve perfusion of the infarcted myocardium, suggesting that they may induce myogenesis as well as angiogenesis.


Subject(s)
Antigens, CD/metabolism , Bone Marrow Cells/metabolism , Bone Marrow Transplantation/methods , Glycoproteins/metabolism , Myocardial Infarction/surgery , Peptides/metabolism , Transplantation, Autologous/methods , AC133 Antigen , Bone Marrow Cells/physiology , Cell Count , Follow-Up Studies , Humans , Prospective Studies , Retrospective Studies , Treatment Outcome
5.
Reprod Biomed Online ; 13(6): 823-32, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17169204

ABSTRACT

Blastomere fragmentation is one of the most significant defects in cleaving embryos. Scientists believed that removing the fragments was a possible way to reduce their unwanted effects. This hypothesis has been tested in some studies in which the development of human fragmented embryos was followed in vivo after all fragments were removed, but little is known about the potential for in-vitro development of such embryos, which is the subject of the present study. For this purpose, 4-6 cell surplus human embryos were scored according to the degree and pattern of fragmentation into four grades, allocated into two groups of control and fragmentation removal (experimental) and cultured sequentially. At the end of day 6 of culture, in the experimental group especially in grade IV blastocyst rate, size and number of blastomeres in each blastocyst were all improved compared with those of the control group (42.3 versus 20.0%; 19,205.7 +/- 1060.3 versus 15,825.9 +/- 448.7 microm(2) and 100.14 +/- 13.48 versus 63.75 +/- 19.79 respectively, P < 0.05). In the grade IV embryos, apoptotic index was also significantly reduced after embryo fragmentation removal (3.40 +/- 0.88 versus 22.99 +/- 4.45, P < 0.05). In conclusion, fragmentation removal had a positive effect on human fragmented embryos and produced the best quality blastocysts.


Subject(s)
Blastocyst/cytology , Adult , Apoptosis , Blastomeres/cytology , Cell Count , Cell Separation , Embryonic Development , Female , Humans , In Vitro Techniques , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...